Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study

Introduction Type 2 diabetes mellitus (T2D) is highly heterogeneous in disease progression and risk of complications. This study aimed to categorize Thai T2D into subgroups using variables that are commonly available based on routine clinical parameters to predict disease progression and treatment o...

Full description

Bibliographic Details
Main Authors: Lukana Preechasuk, Naichanok Khaedon, Varisara Lapinee, Watip Tangjittipokin, Weerachai Srivanichakorn, Apiradee Sriwijitkamol, Nattachet Plengvidhya, Supawadee Likitmaskul, Nuntakorn Thongtang
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/10/6/e003145.full
_version_ 1797785661247324160
author Lukana Preechasuk
Naichanok Khaedon
Varisara Lapinee
Watip Tangjittipokin
Weerachai Srivanichakorn
Apiradee Sriwijitkamol
Nattachet Plengvidhya
Supawadee Likitmaskul
Nuntakorn Thongtang
author_facet Lukana Preechasuk
Naichanok Khaedon
Varisara Lapinee
Watip Tangjittipokin
Weerachai Srivanichakorn
Apiradee Sriwijitkamol
Nattachet Plengvidhya
Supawadee Likitmaskul
Nuntakorn Thongtang
author_sort Lukana Preechasuk
collection DOAJ
description Introduction Type 2 diabetes mellitus (T2D) is highly heterogeneous in disease progression and risk of complications. This study aimed to categorize Thai T2D into subgroups using variables that are commonly available based on routine clinical parameters to predict disease progression and treatment outcomes.Research design and methods This was a cohort study. Data-driven cluster analysis was performed using a Python program in patients with newly diagnosed T2D (n=721) of the Siriraj Diabetes Registry using five variables (age, body mass index (BMI), glycated hemoglobin (HbA1c), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C)). Disease progression and risk of diabetic complications among clusters were compared using the Χ2 and Kruskal-Wallis test. Cox regression and the Kaplan-Meier curve were used to compare the time to diabetic complications and the time to insulin initiation.Results The mean age was 53.4±11.3 years, 58.9% were women. The median follow-up time was 21.1 months (9.2–35.2). Four clusters were identified: cluster 1 (18.6%): high HbA1c, low BMI (insulin-deficiency diabetes); cluster 2 (11.8%): high TG, low HDL-C, average age and BMI (metabolic syndrome group); cluster 3 (23.3%): high BMI, low HbA1c, young age (obesity-related diabetes); cluster 4 (46.3%): older age and low HbA1c at diagnosis (age-related diabetes). Patients in cluster 1 had the highest prevalence of insulin treatment. Patients in cluster 2 had the highest risk of diabetic kidney disease and diabetic retinopathy. Patients in cluster 4 had the lowest prevalence of diabetic retinopathy, nephropathy, and insulin use.Conclusions We were able to categorize Thai patients with newly diagnosed T2D into four clusters using five routine clinical parameters. This clustering method can help predict disease progression and risk of diabetic complications similar to previous studies using parameters including insulin resistance and insulin sensitivity markers.
first_indexed 2024-03-13T00:57:10Z
format Article
id doaj.art-7f240111162146a8844f9008ffb8f289
institution Directory Open Access Journal
issn 2052-4897
language English
last_indexed 2024-03-13T00:57:10Z
publishDate 2022-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Diabetes Research & Care
spelling doaj.art-7f240111162146a8844f9008ffb8f2892023-07-06T18:00:05ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972022-12-0110610.1136/bmjdrc-2022-003145Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort studyLukana Preechasuk0Naichanok Khaedon1Varisara Lapinee2Watip Tangjittipokin3Weerachai Srivanichakorn4Apiradee Sriwijitkamol5Nattachet Plengvidhya6Supawadee Likitmaskul7Nuntakorn Thongtang8Siriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandSiriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandImmunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandSiriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandSiriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDivision of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandSiriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandSiriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandIntroduction Type 2 diabetes mellitus (T2D) is highly heterogeneous in disease progression and risk of complications. This study aimed to categorize Thai T2D into subgroups using variables that are commonly available based on routine clinical parameters to predict disease progression and treatment outcomes.Research design and methods This was a cohort study. Data-driven cluster analysis was performed using a Python program in patients with newly diagnosed T2D (n=721) of the Siriraj Diabetes Registry using five variables (age, body mass index (BMI), glycated hemoglobin (HbA1c), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C)). Disease progression and risk of diabetic complications among clusters were compared using the Χ2 and Kruskal-Wallis test. Cox regression and the Kaplan-Meier curve were used to compare the time to diabetic complications and the time to insulin initiation.Results The mean age was 53.4±11.3 years, 58.9% were women. The median follow-up time was 21.1 months (9.2–35.2). Four clusters were identified: cluster 1 (18.6%): high HbA1c, low BMI (insulin-deficiency diabetes); cluster 2 (11.8%): high TG, low HDL-C, average age and BMI (metabolic syndrome group); cluster 3 (23.3%): high BMI, low HbA1c, young age (obesity-related diabetes); cluster 4 (46.3%): older age and low HbA1c at diagnosis (age-related diabetes). Patients in cluster 1 had the highest prevalence of insulin treatment. Patients in cluster 2 had the highest risk of diabetic kidney disease and diabetic retinopathy. Patients in cluster 4 had the lowest prevalence of diabetic retinopathy, nephropathy, and insulin use.Conclusions We were able to categorize Thai patients with newly diagnosed T2D into four clusters using five routine clinical parameters. This clustering method can help predict disease progression and risk of diabetic complications similar to previous studies using parameters including insulin resistance and insulin sensitivity markers.https://drc.bmj.com/content/10/6/e003145.full
spellingShingle Lukana Preechasuk
Naichanok Khaedon
Varisara Lapinee
Watip Tangjittipokin
Weerachai Srivanichakorn
Apiradee Sriwijitkamol
Nattachet Plengvidhya
Supawadee Likitmaskul
Nuntakorn Thongtang
Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
BMJ Open Diabetes Research & Care
title Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
title_full Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
title_fullStr Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
title_full_unstemmed Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
title_short Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
title_sort cluster analysis of thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes a prospective cohort study
url https://drc.bmj.com/content/10/6/e003145.full
work_keys_str_mv AT lukanapreechasuk clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT naichanokkhaedon clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT varisaralapinee clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT watiptangjittipokin clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT weerachaisrivanichakorn clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT apiradeesriwijitkamol clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT nattachetplengvidhya clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT supawadeelikitmaskul clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy
AT nuntakornthongtang clusteranalysisofthaipatientswithnewlydiagnosedtype2diabetesmellitustopredictdiseaseprogressionandtreatmentoutcomesaprospectivecohortstudy